An in vivo model of SOX9-expressing epidermal cells (SOX9+) as Merkel cell progenitors has been employed for evaluating whether these cells can be reprogrammed toward the neuroendocrine lineage by MCPyV oncoproteins, as occurring in MCC (Weber et al., 2023). The gene discussed is SOX9; the disease is Merkel cell skin cancer.